FRANKFURT (Reuters) - Quarterly underlying core earnings at Bayer, Germany's largest drugmaker, edged 0.4 percent higher as strong demand for its farming pesticides was offset by high raw material costs at its plastics and chemicals unit. First-quarter adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) rose to 2.45 billion euros ($3.18 billion), which was slightly below the average estimate in a Reuters poll of 2.59 billion. ...
via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment